Affibody-mediated peptide nucleic acid pretargeting for delivery of cytotoxic payloads to HER2 positive carcinoma

被引：0
|
作者：
Clinton, Jacob [1 ]
Westerlund, Kristina [1 ]
Karlstrom, Amelie Eriksson [1 ]
Graslund, Torbjorn [1 ]
机构：
[1] Royal Inst Technol, Dept Prot Sci, Stockholm, Sweden
来源：
JOURNAL OF PEPTIDE SCIENCE | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
ID: 11-P1.
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting
    Westerlund, Kristina
    Oroujeni, Maryam
    Gestin, Maxime
    Clinton, Jacob
    Rosly, Alia Hani
    Tano, Hanna
    Vorobyeva, Anzhelika
    Orlova, Anna
    Karlstrom, Amelie Eriksson
    Tolmachev, Vladimir
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (05) : 1595 - 1611
  • [2] Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting
    Westerlund, Kristina
    Vorobyeva, Anzhelika
    Mitran, Bogdan
    Orlova, Anna
    Tolmachev, Vladimir
    Karlstrom, Amelie Eriksson
    Altai, Mohamed
    BIOMATERIALS, 2019, 203 : 73 - 85
  • [3] Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle
    Westerlund, Kristina
    Altai, Mohamed
    Mitran, Bogdan
    Konijnenberg, Mark
    Oroujeni, Maryam
    Atterby, Christina
    de Jong, Marion
    Orlova, Anna
    Mattsson, Johanna
    Micke, Patrick
    Karlstrom, Amelie Eriksson
    Tolmachev, Vladimir
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1092 - 1098
  • [4] Combined treatment of mice bearing HER2-expressing xenografts by trastuzumab and Affibody-mediated PNA-based pretargeting improves their survival
    Oroujeni, M.
    Tano, H.
    Vorobyeva, A.
    Liu, Y.
    Vorontsova, O.
    Xu, T.
    Westerlund, K.
    Orlova, A.
    Tolmachev, V.
    Karlstrom, A. Eriksson
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S158 - S158
  • [5] Development of Peptide Nucleic Acid Probes for Detection of the HER2 Oncogene
    Metaferia, Belhu
    Wei, Jun S.
    Song, Young K.
    Evangelista, Jennifer
    Aschenbach, Konrad
    Johansson, Peter
    Wen, Xinyu
    Chen, Qingrong
    Lee, Albert
    Hempel, Heidi
    Gheeya, Jinesh S.
    Getty, Stephanie
    Gomez, Romel
    Khan, Javed
    PLOS ONE, 2013, 8 (04):
  • [6] Targeting HER2 and FGFR-positive cancer cells with a bispecific cytotoxic conjugate combining anti-HER2 Affibody and FGF2
    Krzyscik, Mateusz A.
    Porebska, Natalia
    Opalinski, Lukasz
    Otlewski, Jacek
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 254
  • [7] HER2 RNA Aptamer- and Cell Penetrating Peptide-Mediated Delivery of Multimeric Antisense Strands of siRNAs for Gene Silencing
    Kang, Sungmuk
    Chae, Woori
    Suh, Sung-Kwan
    Jung, Woong
    Chang, Dong-Jo
    Hah, Sang Soo
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2016, 37 (09) : 1440 - 1444
  • [8] Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer
    Zhang, Chao
    Fu, Shuangqing
    Zhang, Fanghua
    Han, Mengnan
    Wang, Xuming
    Du, Jie
    Zhang, Honglei
    Li, Wei
    NANOMATERIALS, 2022, 12 (04)
  • [9] Novel Lipopolyplexes Using Targeting Branched Peptides Selective For Her2-positive Breast Cancer Optimised For The Delivery Nucleic Acid
    Peregrino, G.
    Kudsiova, L.
    Santin, M.
    TISSUE ENGINEERING PART A, 2022, 28 : 166 - 167
  • [10] Optimizing adeno-associated viral vector-mediated delivery of trastuzumab to the central nervous system for the treatment of Her2 positive brain metastasis.
    Werner, Marcela Salazar
    Aras, Shweta
    Morgan, Ashleigh
    Param, Nesteene J.
    Greig, Jenny
    Wilson, James M.
    CANCER RESEARCH, 2022, 82 (12)
1